To determine predictors of mortality in children on anti-retroviral therapy (ART) who attended the Paediatric HIV Clinic at Kamuzu Central Hospital in Lilongwe, Malawi
Myanmar National AIDS programme's priority is to improve the survival of all people living with HIV ...
Background: Many HIV-infected children in sub-Saharan Africa enter care at a late stage of disease. ...
BACKGROUND: Despite substantial improvements in accessibility of Anti-Retroviral Treatment (ART), de...
To determine predictors of mortality in children on anti-retroviral therapy (ART) who attended the P...
Introduction: Overall outcomes of Human Immunodeficiency Virus infected children on Anti Retroviral ...
BACKGROUND: The introduction of antiretroviral therapy in 1996 improved the longevity and wellbeing ...
Background: The introduction of antiretroviral therapy in 1996 improved the longevity and wellbeing ...
BACKGROUND: An estimated 2.5 million children were living with HIV/AIDS at the end of 2009, 2.3 mill...
Background:Mortality among human immunodeficiency virus-1 (HIV-1) infected children initiated on ant...
Background: Mortality among Human Immunodeficiency Virus-1 (HIV-1) infected children initiated on An...
OBJECTIVES: In children aged less than 15 years, to determine the cumulative proportion of deaths oc...
Prognostic models for children starting antiretroviral therapy (ART) in Africa are lacking. We devel...
Background: In 2017, 64% of children living with HIV in Zambia accessed Antiretroviral Therapy (ART)...
The objective of the study was to determine predictors of survival among HIV-positive children (<15 ...
Objective: To assess mortality and clinical outcomes in children treated with antiretroviral therapy...
Myanmar National AIDS programme's priority is to improve the survival of all people living with HIV ...
Background: Many HIV-infected children in sub-Saharan Africa enter care at a late stage of disease. ...
BACKGROUND: Despite substantial improvements in accessibility of Anti-Retroviral Treatment (ART), de...
To determine predictors of mortality in children on anti-retroviral therapy (ART) who attended the P...
Introduction: Overall outcomes of Human Immunodeficiency Virus infected children on Anti Retroviral ...
BACKGROUND: The introduction of antiretroviral therapy in 1996 improved the longevity and wellbeing ...
Background: The introduction of antiretroviral therapy in 1996 improved the longevity and wellbeing ...
BACKGROUND: An estimated 2.5 million children were living with HIV/AIDS at the end of 2009, 2.3 mill...
Background:Mortality among human immunodeficiency virus-1 (HIV-1) infected children initiated on ant...
Background: Mortality among Human Immunodeficiency Virus-1 (HIV-1) infected children initiated on An...
OBJECTIVES: In children aged less than 15 years, to determine the cumulative proportion of deaths oc...
Prognostic models for children starting antiretroviral therapy (ART) in Africa are lacking. We devel...
Background: In 2017, 64% of children living with HIV in Zambia accessed Antiretroviral Therapy (ART)...
The objective of the study was to determine predictors of survival among HIV-positive children (<15 ...
Objective: To assess mortality and clinical outcomes in children treated with antiretroviral therapy...
Myanmar National AIDS programme's priority is to improve the survival of all people living with HIV ...
Background: Many HIV-infected children in sub-Saharan Africa enter care at a late stage of disease. ...
BACKGROUND: Despite substantial improvements in accessibility of Anti-Retroviral Treatment (ART), de...